甲状腺乳头状癌手术方式选择与争议
|
摘要
近年来,甲状腺癌发病率逐年上升,治疗方式主要为手术治疗,并与预后密切相关。然而甲状腺癌手术方式如何选择,国内外众说纷纭。美国国立综合癌症网(NCCN)以及美国甲状腺协会(ATA)最新指南中,甲状腺乳头状癌手术方式均有调整。本文探讨各指南在手术方式上存在的争议之处,并对其术式选择进行阐述。
引文
[1]Lee JH,Shin SW.Overdiagnosis and screening for thyroid cancer in Korea[J].Lancet,2014,384(9957):1848-1848.
[2]Zhang L,Wei WJ,Ji QH,et al.Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma:a study of 1066 patients[J].J Clin Endocrinol Metab,2012,97(4):1250-1257.
[3]中华医学会内分泌学分会,中华医学会外科学分会,中国抗癌协会头颈肿瘤专业委员会,中华医学会核医学分会.甲状腺结节和分化型甲状腺癌诊治指南[J].中国肿瘤临床,2012,39(17):1249-1272.
[4]Haugen BR,Alexander EK,Bible KC,et al.2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer:The American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer[J].Thyroid,2016,26(1):1-133.
[5]郑向前,候秀坤,高明.2017年第二版NCCN甲状腺肿瘤指南解读[J].中国肿瘤临床,2018,45(1):14-17.
[6]Pacini F,Castagna MG,Pentheroudakis LBG.Thyroid cancer:ESMOclinical practice guidelines fordiagnosis,treatment and follow-up[J].Ann Oncol,2010,21(suppl 5):214-219.
[7]Ito Y,Miyauchi A,Kihara M,et al.Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation[J].Thyroid,2014,24(1):27-34.
[8]Sugitani I,Toda K,Yamada K,et al.Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized:our treatment strategies and outcomes[J].World J Surg,2010,34(6):1222-1231.
[9]Li F,Chen G,Sheng C,et al.BRAF V600E mutation in papillary thyroid microcarcinoma:a meta-analysis[J].Endocr Relat Cancer,2015,22(2):159-168.
[10]Zhou YL,Zhang W,Gao EL,et al.Preoperative BRAF mutation is predictive of occult contralateral caracinoma in patients with unilateral papillary thyroid microcarcinoma[J].Asian Pac J Cancer Prev,2012,13(4):1267-1272.
[11]Mitchell I,Livingston FH,Chang AY,et al.Trends in thyroidcancer demographics and surgical surgery in the United States[J].Surgery,2007,42(6):823.
[12]姜洪池.甲状腺全切除手术的必要性及安全性[J].中华普通外科杂志,2010,25(8):609-610.
[13]Esnaola NF,Cantor SB,Sherman SI,et al.optimal treatment strategy in patients with papillary thyroid cancer:a decision analysis[J].Surgery,2001,130(6):921-930.
[14]Gimm O,Brauckhoff M,Thanh PN,et al.an update on thyroid surgery[J].Eur J Nucl Med Imaging,2002,29(suppl 2):447-452.
[15]Hundahl SA,Cady B,Cunninqham MP,et al.initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996.US and german thyroid cancer study group[J].Cancer,2000,89(1):202-217.
[16]李小毅.2015年美国甲状腺学会《成人甲状腺结节与分化型甲状腺癌诊治指南》解读:外科部分[J].中国癌症杂志,2016,26(1):13-18.
[17]刘文,程若川,苏艳军,等.2015版美国甲状腺协会指南cN0甲状腺乳头状癌手术方案合理性分析[J].中国实用外科杂志,2017,37(5):568-571.
[18]So YK,Kim MJ,Kim S,et al.Lateral lymph node metastasis in papillary thyroid carcinoma:A systematic review and meta-analysis for prevalence,risk factors,and location[J].Int J Surg,2018,50:94-103.
[19]Niemann AC,Reid AT,Smith J,et al.Association of patient age with high-risk pathologic features in papillary thyroid cancer[J].JSurg Res,2017,211:228-232.
[20]Ito Y,Miyauchi A,Kihara M,et al.Prognostic significance of young age in papillary thyroid carcinoma:analysis of 5,733 patients with 150 months'median follow-up[J].Endocr J,2014,61(5):491.
[21]Lee SH,Roh JL,Gong G,et al.Risk Factors for Recurrence After Treatment of N1b Papillary Thyroid Carcinoma[J].Ann Surg,2018:1.
[22]Liu Z,Lei J,Liu Y,et al.Preoperative predictors of lateral neck lymph node metastasis in papillary thyroid microcarcinoma[J].Medicine,2017,96(10):e6240.
[23]Sun W,Lan X,Zhang H,et al.Risk Factors for Central Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma:A Systematic Review and Meta-Analysis[J].Plos One,2015,10(10):e0139021.
[24]Roh JL,Kim JM,Park CI.Central lymph node metastasis of unilateral papillary thyroid carcinoma:patterns and factors predictive of nodal metastasis,morbidity,and recurrence[J].Ann Surg Oncol,2011,18(8):2245-2250.
[25]王蕴君,吴毅.单侧分化型甲状腺癌对侧中央区淋巴结转移的相关危险因素及治疗现状[J].中国实用外科杂志,2013,33(6):526-528.
[26]张帅,蒋孝会.伴有侧颈区淋巴结转移的甲状腺乳头状癌患者不同年龄组的临床特征分析[J].临床耳鼻咽喉头颈外科杂志,2018,32(17):1319-1324
[27]Rondeau G,Fish S,Hann LE,et al.Ultrasonographically detected small thyroid bed nodules identified after total thyroidectomy for differentiated thyroid cancer seldom show clinically significant structural progression[J].Thyroid,2011,21(8):845-853.
[28]Robenshtok E,Fish S,Bach A,et al.Suspicious cervical lymph nodes detected after thyroidectomy for papillary thyroid cancer usually remain stable over years in properly selected patients[J].JClin Endocrinol Metab,2012,97(8):2706-2713.
[29]孙荣昊,李超,樊晋川,等.中央区淋巴清扫术对初治分化型甲状腺癌临床价值的Meta分析[J].中华耳鼻咽喉头颈外科学杂志,2014,49(2):157-164.
[30]So YK,Seo MY,Son YI.Prophylactic central lymph node dissection for clinically node-negative papillary thyroid microcarcinoma:influence on serum thyroglobulin level,recurrence rate,and postoperative complications[J].Surgery,2012,151(2):192.
[31]Ryu IS,Chan IS,Choi SH,et al.Lymph Node Ratio of the Central Compartment is a Significant Predictor for Locoregional Recurrence After Prophylactic Central Neck Dissection in Patients with Thyroid Papillary Carcinoma[J].Ann Surg Oncol,2014,21(1):277-283.
[32]马芳花,黄品同,戚瑞祥,等.超声引导下微波消融治疗甲状腺微小乳头状癌与外科手术切除的研究[J].中国超声医学杂志,2017,(5):399-402.
[33]刘雪平,黄继光,周余旺,等.超声引导下微小乳头状癌射频消融临床应用[J].医学影像学杂志,2016,26(11):1970-1973.
[34]Garberoglio R,Aliberti C,Appetecchia M,et al.Radiofrequency ablation for thyroid nodules:which indications The first Italian opinion statement[J].J Ultras,2015,18(4):423-430.
[35]Ma B,Wang Y,Yang S,et al.Predictive Factors for Central Lymph Node Metastasis in Patients with CN0 Papillary Thyroid Carcinoma:A Systematic Review and Meta-Analysis[J].Int J Surgy,2016,28:153-161.
[2]Zhang L,Wei WJ,Ji QH,et al.Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma:a study of 1066 patients[J].J Clin Endocrinol Metab,2012,97(4):1250-1257.
[3]中华医学会内分泌学分会,中华医学会外科学分会,中国抗癌协会头颈肿瘤专业委员会,中华医学会核医学分会.甲状腺结节和分化型甲状腺癌诊治指南[J].中国肿瘤临床,2012,39(17):1249-1272.
[4]Haugen BR,Alexander EK,Bible KC,et al.2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer:The American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer[J].Thyroid,2016,26(1):1-133.
[5]郑向前,候秀坤,高明.2017年第二版NCCN甲状腺肿瘤指南解读[J].中国肿瘤临床,2018,45(1):14-17.
[6]Pacini F,Castagna MG,Pentheroudakis LBG.Thyroid cancer:ESMOclinical practice guidelines fordiagnosis,treatment and follow-up[J].Ann Oncol,2010,21(suppl 5):214-219.
[7]Ito Y,Miyauchi A,Kihara M,et al.Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation[J].Thyroid,2014,24(1):27-34.
[8]Sugitani I,Toda K,Yamada K,et al.Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized:our treatment strategies and outcomes[J].World J Surg,2010,34(6):1222-1231.
[9]Li F,Chen G,Sheng C,et al.BRAF V600E mutation in papillary thyroid microcarcinoma:a meta-analysis[J].Endocr Relat Cancer,2015,22(2):159-168.
[10]Zhou YL,Zhang W,Gao EL,et al.Preoperative BRAF mutation is predictive of occult contralateral caracinoma in patients with unilateral papillary thyroid microcarcinoma[J].Asian Pac J Cancer Prev,2012,13(4):1267-1272.
[11]Mitchell I,Livingston FH,Chang AY,et al.Trends in thyroidcancer demographics and surgical surgery in the United States[J].Surgery,2007,42(6):823.
[12]姜洪池.甲状腺全切除手术的必要性及安全性[J].中华普通外科杂志,2010,25(8):609-610.
[13]Esnaola NF,Cantor SB,Sherman SI,et al.optimal treatment strategy in patients with papillary thyroid cancer:a decision analysis[J].Surgery,2001,130(6):921-930.
[14]Gimm O,Brauckhoff M,Thanh PN,et al.an update on thyroid surgery[J].Eur J Nucl Med Imaging,2002,29(suppl 2):447-452.
[15]Hundahl SA,Cady B,Cunninqham MP,et al.initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996.US and german thyroid cancer study group[J].Cancer,2000,89(1):202-217.
[16]李小毅.2015年美国甲状腺学会《成人甲状腺结节与分化型甲状腺癌诊治指南》解读:外科部分[J].中国癌症杂志,2016,26(1):13-18.
[17]刘文,程若川,苏艳军,等.2015版美国甲状腺协会指南cN0甲状腺乳头状癌手术方案合理性分析[J].中国实用外科杂志,2017,37(5):568-571.
[18]So YK,Kim MJ,Kim S,et al.Lateral lymph node metastasis in papillary thyroid carcinoma:A systematic review and meta-analysis for prevalence,risk factors,and location[J].Int J Surg,2018,50:94-103.
[19]Niemann AC,Reid AT,Smith J,et al.Association of patient age with high-risk pathologic features in papillary thyroid cancer[J].JSurg Res,2017,211:228-232.
[20]Ito Y,Miyauchi A,Kihara M,et al.Prognostic significance of young age in papillary thyroid carcinoma:analysis of 5,733 patients with 150 months'median follow-up[J].Endocr J,2014,61(5):491.
[21]Lee SH,Roh JL,Gong G,et al.Risk Factors for Recurrence After Treatment of N1b Papillary Thyroid Carcinoma[J].Ann Surg,2018:1.
[22]Liu Z,Lei J,Liu Y,et al.Preoperative predictors of lateral neck lymph node metastasis in papillary thyroid microcarcinoma[J].Medicine,2017,96(10):e6240.
[23]Sun W,Lan X,Zhang H,et al.Risk Factors for Central Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma:A Systematic Review and Meta-Analysis[J].Plos One,2015,10(10):e0139021.
[24]Roh JL,Kim JM,Park CI.Central lymph node metastasis of unilateral papillary thyroid carcinoma:patterns and factors predictive of nodal metastasis,morbidity,and recurrence[J].Ann Surg Oncol,2011,18(8):2245-2250.
[25]王蕴君,吴毅.单侧分化型甲状腺癌对侧中央区淋巴结转移的相关危险因素及治疗现状[J].中国实用外科杂志,2013,33(6):526-528.
[26]张帅,蒋孝会.伴有侧颈区淋巴结转移的甲状腺乳头状癌患者不同年龄组的临床特征分析[J].临床耳鼻咽喉头颈外科杂志,2018,32(17):1319-1324
[27]Rondeau G,Fish S,Hann LE,et al.Ultrasonographically detected small thyroid bed nodules identified after total thyroidectomy for differentiated thyroid cancer seldom show clinically significant structural progression[J].Thyroid,2011,21(8):845-853.
[28]Robenshtok E,Fish S,Bach A,et al.Suspicious cervical lymph nodes detected after thyroidectomy for papillary thyroid cancer usually remain stable over years in properly selected patients[J].JClin Endocrinol Metab,2012,97(8):2706-2713.
[29]孙荣昊,李超,樊晋川,等.中央区淋巴清扫术对初治分化型甲状腺癌临床价值的Meta分析[J].中华耳鼻咽喉头颈外科学杂志,2014,49(2):157-164.
[30]So YK,Seo MY,Son YI.Prophylactic central lymph node dissection for clinically node-negative papillary thyroid microcarcinoma:influence on serum thyroglobulin level,recurrence rate,and postoperative complications[J].Surgery,2012,151(2):192.
[31]Ryu IS,Chan IS,Choi SH,et al.Lymph Node Ratio of the Central Compartment is a Significant Predictor for Locoregional Recurrence After Prophylactic Central Neck Dissection in Patients with Thyroid Papillary Carcinoma[J].Ann Surg Oncol,2014,21(1):277-283.
[32]马芳花,黄品同,戚瑞祥,等.超声引导下微波消融治疗甲状腺微小乳头状癌与外科手术切除的研究[J].中国超声医学杂志,2017,(5):399-402.
[33]刘雪平,黄继光,周余旺,等.超声引导下微小乳头状癌射频消融临床应用[J].医学影像学杂志,2016,26(11):1970-1973.
[34]Garberoglio R,Aliberti C,Appetecchia M,et al.Radiofrequency ablation for thyroid nodules:which indications The first Italian opinion statement[J].J Ultras,2015,18(4):423-430.
[35]Ma B,Wang Y,Yang S,et al.Predictive Factors for Central Lymph Node Metastasis in Patients with CN0 Papillary Thyroid Carcinoma:A Systematic Review and Meta-Analysis[J].Int J Surgy,2016,28:153-161.